• Michael R Verneris, Stephanie J Lee, Kwang Woo Ahn, Hai-Lin Wang, Minoo Battiwalla, Yoshihiro Inamoto, Marcelo A Fernandez-Vina, James Gajewski, Joseph Pidala, Reinhold Munker, Mahmoud Aljurf, Wael Saber, Stephen Spellman, and John Koreth.
• Department of Pediatric BMT, University of Minnesota, Minneapolis, Minnesota. Electronic address: verneris@umn.edu.
• Biol. Blood Marrow Transplant. 2015 Oct 1; 21 (10): 1783-9.

AbstractOver the past 2 decades, reduced-intensity conditioning allogeneic hematopoietic cell transplantation (RIC HCT) has increased substantially. Many patients do not have fully HLA-matched donors, and the impact of HLA mismatch on RIC HCT has not been examined in large cohorts. We analyzed 2588 recipients of 8/8 HLA-high resolution matched (n = 2025) or single-locus mismatched (n = 563) unrelated donor (URD) RIC HCT from 1999 to 2011. Overall survival (OS) was the primary outcome. Secondary endpoints included treatment-related mortality (TRM), relapse, disease-free survival (DFS), and acute/chronic graft-versus-host disease (GVHD). Adjusted 1- and 3-year OS was better in 8/8- versus 7/8-matched recipients (54.7% versus 48.8%, P = .01, and 37.4% versus 30.9%, P = .005, respectively). In multivariate models 7/8 URD RIC HCT recipients had more grades II to IV acute GVHD (RR = 1.29, P = .0034), higher TRM (RR = 1.52, P < .0001), and lower DFS (RR = 1.12, P = .0015) and OS (RR = 1.25, P = .0001), with no difference in relapse or chronic GVHD. In subgroup analysis, inferior transplant outcomes were noted regardless of the HLA allele mismatched. Previously reported permissive mismatches at HLA-C (C*03:03/C*03:04) and HLA-DP1 (based on T cell-epitope matching) were not associated with better outcomes. Although feasible, single-locus mismatch in RIC URD HCT is associated with inferior outcomes.Copyright © 2015 American Society for Blood and Marrow Transplantation. All rights reserved.

36 keywords...

hide…